China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study on the Titration Treatment of Patients with Moderate to Severe Cancer Pain Using Oxybutynin Naloxone Extended-Release Tablets'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132817
Registration Time: 2026/09/18
Type: Interventional study
Primary Sponsor: Shandong Provincial Hospital (Shandong Children's Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343776
Published by HT Digital Content Services with permission from Health Daily Digest....